Latest News

September 30, 2003
UCSF has opened a new Arthritis and Joint Replacement Center -- a joint effort between the departments of rheumatology and orthopedic surgery.
September 25, 2003
By tinkering with a few of the parts in a vital signaling circuit found in human cells, UCSF scientists have demonstrated the possibility of an entirely new technology: developing new devices or therapies by mixing and matching sub-cellular signaling components.
September 20, 2003
Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.
September 19, 2003
Researchers at the San Francisco VA Medical Center (SFVAMC) have taken the first major step toward isolating adult stem cells from mouse skin, having developed a test that confirms the presence and number of stem cells in a given amount of tissue.
September 17, 2003
UCSF researchers have been funded by the National Institutes of Health to study the antiretroviral drug tenofovir as a potential pre-exposure prophylaxis in Cambodia among high-risk, HIV-uninfected women.
September 14, 2003
Scientists at UCSF and Massachusetts General Hospital (MGH) have found strong evidence that a cell signaling pathway active in embryonic development plays a crucial role in pancreatic cancer.
September 10, 2003
UCSF researchers have identified a biochemical feedback system in rats that could explain why some people crave comfort foods - such as chocolate chip cookies and greasy cheeseburgers - when they are chronically stressed, and why such people are apt to gain weight in the abdomen.
August 25, 2003
Workplace exposure to dust or fumes may account for as many as five million cases of emphysema, chronic bronchitis and related diseases in the U.S. - diseases that have been mainly attributed to smoking, a new University of California, San Francisco survey shows.
August 25, 2003
Researchers have had few clues as to why Black women are more likely to die from heart attacks or strokes than white women.
August 20, 2003
Resistance mutations to anti-HIV medications are more likely to occur in patients who take most of their medications rather than in those who don't, according to AIDS specialists at the University of California, San Francisco.